Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT02254239 · TERMINATED
Trial details
- NCT number
- NCT02254239
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-04
- Primary completion
- 2018-12-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.